Disclosures

Fertility Nutraceuticals, LLC (FNC) collaborated with the Center for Human Reproduction (CHR) in developing its first product, FERTINATAL®, which is endorsed by the CHR. CHR owns four U.S. patents on the effects of DHEA on female fertility. FNC is licensed to cite these patents, and pays CHR patent licensing fees. In addition, Norbert Gleicher, MD, who is the owner of CHR and listed as co-inventor on these patents, is a shareholder of FNC and receives patent licensing fees from FNC.

FNC consulted Robert F Casper, MD, Senior Scientist at Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Toronto, Canada, to develop OVOENERGEN™ CoQ10. Dr. Casper endorses OVOENERGEN™ CoQ10 for women’s fertility. FNC is licensed to cite Dr. Casper’s research findings on CoQ10, antioxidants, egg development and women’s fertility, and pays licensing fees to Dr. Casper.